Clinical Study on Kesh21 Hair Oil for Hair Growth Potential
- Registration Number
- CTRI/2023/07/054992
- Lead Sponsor
- OnTop Pharmaceuticals Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Clinically healthy adults subjects between the ages 21 and 55 years (both ages and genders inclusive) looking to improve their hair growth potential.
2.Subjects who agree not to dye/color, cut/trim, perming, straightening or other cosmetic treatments and /or undergo any hair treatments not limited to hair spa at beauty saloons/parlours for the duration of participation in the clinical study.
3.Subjects with complaints of non-associated excessive hair fall, brittle/thin hair, dull hair, dry/damaged hair.
4.Subjects who are willing to abstain from the use of any dedicated products not limited to hair oil, shampoo, conditioner, hair mask, hair serum, hair treatments and home remedies to improve hair fall and other hair health parameters.
5.Subjects who are willing to abstain from the use of any oral /topical medications not limited to collagen, biotin supplements indicated and improving hair fall and other hair health parameters.
6.Subject who are willing to give informed consent for participation, able to comprehened and understand the responsibilities during screening and treatment period.
7.Subjects who are willing not to participate in any other clinical trail during participation in the current trail.
1.Subject with known hypersenstivity to the ingredients of the investigational product.
2.Subjects who had an active trichological procedure done upto 3 months prior to screening
3.subjects who have dyed their hair upto 30 days prior to screening.
4.Subjects who have scalp conditions not limited to seborrheic dermatitis, psoriasis, alopecia areata, significant scalp scarring that prevents proper examination or evaluation of study criteria
5.Subjects with trichotillomania
6.Subjects who have anemia or iron deficiency
7.Subjects who have previously undergone hair transplantation
8.Subjects who have an active infection, disease or disorder that will prevent them from fully satisfying the responsibilities of the study.
9.Subjects with history of seizures, uncontrolled diabetes, hypertension or major cardiac illness like congestive heart failure etc.
10.Subjects suffering from /on remission from cancer of any type less than 5 years at the time of screening
11.Subjects who are planning a pregnancy and /or currently breastfeeding.
12.Subjects who have participated in a clinical study less than 1 month before screening.
13.Any significant medical condition (eg., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.), any medical condition that is unstable/ poorly controlled or other factors (eg ., planned relocation ) that the investigator felt would interfere with study evaluations and study participation.
14.Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol
15.Subjects who in the opinion of the investigator are not eligible for enrolment in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Visual Scalp Assessment : Increase of greater than or equal to 10 from baseline <br/ ><br>2.Hair Growth Questionnaire : Total score lesser than or equal to 10 at the end of the study <br/ ><br>3.Product satisfaction Questionnaire : Total score lesser than or equal to 5 at the end of the study <br/ ><br>Timepoint: 1.Visual Scalp Assessment : Day1, Day45, Day90 <br/ ><br>2.Hair Growth Questionnaire : Day45, Day90 <br/ ><br>3.Product satisfaction Questionnaire : Day 90 <br/ ><br>
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable